Delivery Order SPE2DB24D1006-SPE2DB25FCEFT

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,409.30, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of February 5, 2025. The contract was awarded on February 4, 2025 and does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $10,968.25 for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price award. This contract is part of a larger $999,999,999 Indefinite Delivery...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,245.64, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has a firm fixed price pricing type and is a delivery order with a completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,790.12, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,518.14 firm fixed-price contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a prescription medication. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $7,135.33, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,251.28, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 28, 2025. The contract is not designated as a set-aside. This award is part of a...
This is a $17,066.03 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a specialty medication, with an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,133.30, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used in the treatment of diabetes. The award has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $86,326.45 firm fixed-price contract is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used for diabetes management. The contract has an ultimate completion date of January 13, 2025. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D1006
    Indefinite Delivery Contract
  • SPE2DB24D1006-SPE2DB25FCEFT
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,239.03, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 13, 2025. The contract was awarded on February 12, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/14/25, 10:16 AM